tiprankstipranks
Trending News
More News >

Noxopharm Reduces Stake in Nyrada Inc.

Story Highlights
Noxopharm Reduces Stake in Nyrada Inc.

Don’t Miss TipRanks’ Half-Year Sale

An update from Noxopharm Ltd. ( (AU:NOX) ) is now available.

Noxopharm Limited has significantly reduced its holding in Nyrada Inc., decreasing its voting power from 18.60% to 5.13%. This change in substantial holding may impact Nyrada’s shareholder dynamics and influence within the company, potentially affecting its strategic decisions and market perception.

More about Noxopharm Ltd.

Nyrada Inc. is a biotechnology company specializing in the discovery and development of innovative small-molecule therapies. The company focuses on targeting Transient Receptor Potential Canonical (TRPC) ion channels, with its lead candidate, NYR-BI03, currently undergoing a Phase I clinical trial for neuroprotection and cardioprotection. Nyrada is incorporated in Delaware, USA.

Average Trading Volume: 93,059

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$20.46M

For a thorough assessment of NOX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1